Fig. 6: CircKDM4C inhibited breast cancer cell progression and doxorubicin resistance through protecting PBLD from miR-548p-induced degradation.
l Transwell assays revealed that PBLD knockdown promoted migration and invasion abilities of breast cancer cells (**P < 0.01; ***P < 0.001).
